West Branch Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.38K | Hold |
78
| – | – | ﹤0.01% | 323 |
|
|
2025
Q1 | $5.42K | Hold |
78
| – | – | ﹤0.01% | 338 |
|
|
2024
Q4 | $6.71K | Sell |
78
-5
| -6% | -$430 | ﹤0.01% | 313 |
|
|
2024
Q3 | $9.9K | Buy |
83
+5
| +6% | +$596 | ﹤0.01% | 277 |
|
|
2024
Q2 | $11.1K | Hold |
78
| – | – | ﹤0.01% | 266 |
|
|
2024
Q1 | $10K | Hold |
78
| – | – | ﹤0.01% | 275 |
|
|
2023
Q4 | $8.07K | Hold |
78
| – | – | ﹤0.01% | 294 |
|
|
2023
Q3 | $7.09K | Hold |
78
| – | – | ﹤0.01% | 305 |
|
|
2023
Q2 | $6.31K | Hold |
78
| – | – | ﹤0.01% | 322 |
|
|
2023
Q1 | $6.21K | Sell |
78
-152
| -66% | -$12.1K | ﹤0.01% | 331 |
|
|
2022
Q4 | $15.6K | Hold |
230
| – | – | 0.01% | 246 |
|
|
2022
Q3 | $11K | Hold |
230
| – | – | 0.01% | 277 |
|
|
2022
Q2 | $13K | Hold |
230
| – | – | 0.01% | 256 |
|
|
2022
Q1 | $13K | Hold |
230
| – | – | 0.01% | 270 |
|
|
2021
Q4 | $13K | Hold |
230
| – | – | 0.01% | 302 |
|
|
2021
Q3 | $11K | Hold |
230
| – | – | 0.01% | 301 |
|
|
2021
Q2 | $10K | Buy |
+230
| New | +$10K | ﹤0.01% | 325 |
|